Epidemiology, pathophysiology, prognosis, and treatment of systolic and diastolic heart failure

Cardiology in Review
Wilbert S Aronow

Abstract

Underlying causes, risk factors, and precipitating causes of heart failure (HF) should be treated. Drugs known to precipitate or aggravate HF such as nonsteroidal antiinflammatory drugs should be stopped. Patients with HF and a low left ventricular ejection fraction (systolic heart failure) or normal ejection fraction (diastolic HF) should be treated with diuretics if fluid retention is present, with an angiotensin-converting enzyme (ACE) inhibitor or an angiotensin receptor blocker if the patient cannot tolerate an ACE inhibitor because of cough, angioneurotic edema, rash, or altered taste sensation, and with a beta blocker unless contraindicated. If severe systolic HF persists, an aldosterone antagonist should be added. If HF persists, isosorbide dinitrate plus hydralazine should be added. Calcium channel blockers should be avoided if systolic HF is present. Digoxin should be avoided in men and women with diastolic HF if sinus rhythm is present and in women with systolic HF. Digoxin should be given to men with systolic HF if symptoms persist, but the serum digoxin level should be maintained between 0.5 and 0.8 ng/mL.

References

Dec 1, 1992·Journal of the American College of Cardiology·D HallW Rudolph
Mar 10, 1991·Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine·H Yasuda
Aug 1, 1991·Stroke; a Journal of Cerebral Circulation·P A WolfW B Kannel
Mar 1, 1991·American Heart Journal·W B Kannel, A J Belanger
Apr 15, 1991·The American Journal of Cardiology·W J ManningJ Y Wei
Aug 1, 1991·The New England Journal of Medicine·UNKNOWN SOLVD InvestigatorsJay N Cohn
Jan 1, 1990·Free Radical Biology & Medicine·B Bandy, A J Davison
Jan 1, 1989·British Journal of Clinical Pharmacology·P M VanhoutteM J Vidal
Jun 15, 1989·The American Journal of Cardiology·W F WongP L Blanchette
Aug 18, 1988·The New England Journal of Medicine·UNKNOWN Multicenter Diltiazem Postinfarction Trial Research Group
Dec 1, 1986·Giornale italiano di cardiologia·S Scardi
Jan 1, 1969·Gerontologia·F Verzár
Sep 27, 1984·The New England Journal of Medicine·J N CohnT Rector
Mar 26, 1982·JAMA : the Journal of the American Medical Association
Oct 1, 1994·The American Journal of Cardiology·H L KennedyS Goldstein
Dec 1, 1994·Journal of the American Geriatrics Society·W S Aronow
Mar 27, 1993·Lancet·J Lob-levyt

❮ Previous
Next ❯

Citations

Sep 28, 2007·Comprehensive Therapy·Wilbert S Aronow
May 7, 2008·Pflügers Archiv : European journal of physiology·Janos AlmassyIstvan Jona
Nov 16, 2007·Comprehensive Therapy·Wilbert S Aronow
Nov 21, 2007·Comprehensive Therapy·Wilbert S Aronow
Apr 22, 2010·Vascular Health and Risk Management·Ankur SandhuAnatole Besarab
May 26, 2012·Trends in Cardiovascular Medicine·Dajun Wang, John O'Horo
Feb 1, 2012·Biochimie·Thangaiyan RadhigaKodukkur Viswanathan Pugalendi
Sep 1, 2011·Archives of Physical Medicine and Rehabilitation·Rebecca A GarySandra B Dunbar
Oct 26, 2010·Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography·John S NguyenHisham Dokainish
Jul 29, 2009·The American Journal of Medicine·Michael A Chen
May 19, 2009·European Journal of Pharmacology·Shou-bao WangGuan-hua Du
Nov 21, 2008·Journal of Veterinary Cardiology : the Official Journal of the European Society of Veterinary Cardiology·Dan G OhadRona Shofti
Nov 11, 2008·Heart & Lung : the Journal of Critical Care·Rebecca Gary, Leslie Davis
Apr 4, 2008·European Journal of Pharmacology·Ru ZhouGuidong Dai
Oct 13, 2007·Journal of the American Medical Directors Association·Madhavi KokaWilbert S Aronow
Sep 14, 2006·European Journal of Clinical Investigation·K G ShyuH Chang
Aug 2, 2008·Clinics in Geriatric Medicine·Wilbert S Aronow
Apr 10, 2016·The American Journal of Medicine·Qin M Chen, Joseph S Alpert
Apr 14, 2016·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·Mukesh KumarMangala Lahkar
Jul 15, 2015·Revista Portuguesa De Cardiologia : Orgão Oficial Da Sociedade Portuguesa De Cardiologia = Portuguese Journal of Cardiology : an Official Journal of the Portuguese Society of Cardiology·Lucía Martínez-BrañaFrancisco Luis Lado Lado
Feb 19, 2011·European Journal of Cardiovascular Nursing : Journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology·Donna Fitzsimons, Patricia H Strachan
Feb 9, 2008·Physical Therapy·Birgitta Blakstad NilssonMay Arna Risberg
Dec 31, 2010·Journal of Cardiovascular Pharmacology and Therapeutics·Veeraraghavan GayathriHannah R Vasanthi
May 15, 2008·The Annals of Pharmacotherapy·Roy C Parish, Jeffery D Evans
Jul 6, 2007·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Wilhelm Schoner, Georgios Scheiner-Bobis
May 15, 2007·American Journal of Physiology. Cell Physiology·Wilhelm Schoner, Georgios Scheiner-Bobis
Apr 26, 2020·Journal of Personalized Medicine·Federica CosentinoSalvatore Pasta

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.